Incidence,mortality,and disability-adjusted life years of female breast cancer in China,2022OACSTPCDMEDLINE
Incidence,mortality,and disability-adjusted life years of female breast cancer in China,2022
Kexin Sun;Yifei Yao;Peiqing Ma;Shaoming Wang;Ru Chen;Bingfeng Han;Wenqiang Wei;Jie He;Bailin Zhang;Shaoyuan Lei;Rongshou Zheng;Xin Liang;Li Li;Xiaolong Feng;Siwei Zhang;Hongmei Zeng
Office of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaDepartment of Pathology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaDepartment of Thoracic Surgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaDepartment of Breast Surgical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaDepartment of Evidence-Based Medicine,Xuanwu Hospital,Capital Medical University,Beijing 100053,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaMedical Statistics Office,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaDepartment of Pathology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China
FemaleBreast cancerIncidenceMortalityDALYsChinaEarly detection of cancerDisease burdenInvasive breast carcinomaQuality of life
FemaleBreast cancerIncidenceMortalityDALYsChinaEarly detection of cancerDisease burdenInvasive breast carcinomaQuality of life
《中华医学杂志(英文版)》 2024 (20)
2429-2436,8
This work was supported by a grant from the CAMS Innovation Fund for Medical Sciences(No.2021-I2M-1-011).
评论